Transparency Market
Research
Kidney Cancer Drugs Market - Global Industry Analysis,
Pipeline Analysis, Size, Share, Growth, Trends and
Forecast 2014 - 2020
Published Date
2015-01-23
82 Page Report
Buy Now
Request Sample
Press Release
Kidney Cancer Drugs Market Expected to Reach USD 4.5 Billion
Globally in 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Kidney Cancer Drugs Market
REPORT DESCRIPTION
Kidney Cancer Drugs Market
- Global Industry Analysis, Pipeline Analysis,
Size, Share, Growth, Trends and Forecast 2014 – 2020
Kidneys are among the most crucial organs of the human body. Their role in
regulating blood pressure and serving homeostatic functions is critical in
maintaining the balance of nutrients and toxins in the body. Kidneys serve as
natural blood filters, removing the water-soluble wastes and reabsorbing the
essential elements from the blood. Since they play such a crucial role, kidneys
require constant regeneration of dead nephrons and proper blood circulation to
maintain healthy cell growth, due to which, they are susceptible to metastasis and
cancerous tumors. Renal cell carcinoma, the most common type of kidney cancer,
is among the toughest cancers to treat, especially in the advanced stages. Until
1980’s, the treatment of kidney cancer included surgical removal of the kidneys.
The treatment later progressed to laparoscopic removal of the tumor-affected part
of the kidneys, significantly increasing the survival rate and patient comfort.
Drugs are usually given to stage four advanced renal cell carcinoma patients with
disease progression. Various forms of cancer treatment mechanism have been
implemented among the presently approved drugs for kidney cancer; these
include, VEGF (Vascular Endothelial Growth Factor) inhibitor, angiogenesis
inhibitor,...